Lupin Completes Acquisition of Aarane™ and Nalcrom™ Brands from Sanofi in Europe and Canada

Global pharma major Lupin Limited has completed the acquisition of two brands, Aarane™ in Germany and Nalcrom™ in Canada and the Netherlands, along with the associated trademark rights, from Sanofi. The acquisition aligns with Lupin's strategy to grow its global presence in Specialty areas, where the company has a leading position, with high-quality products that are innovative or unique in the market. This acquisition will enhance Lupin's Respiratory business in Germany and add accretive assets in gastro-intestinal care. Lupin is committed to providing the best products and services in the market segments where it is present, improving the quality of life for millions of people around the world.